CEREBROLYSIN

Cerebrolysin has been shown in clinical research to be effective in the treatment of Alzheimer’s disease (AD) because it has been shown to improve synapse function and lower amyloid deposition. Cerebrolysin injection has been proven to have nerve growth factors and protects neurons from free radicals, improve the metabolic activity of neurons, and cause peripheral and central neuronal stimulation. The neuroprotective properties of Cerebrolysin shield neurons from lactocidosis.